We plan to continue our studies on the action of antidepressant drugs on the regulation of recognition and action function of the norepinephrine (NE) receptor coupled adenylate cyclase system in brain. Since atypical antidepressants (e.g. fluoxetine, alaproclate, alprazolam) do not or not consistently alter the sensitivity of the NE sensitive adenylate cyclase or the density of its Beta-adrenoceptor subpopulation in normal animals, we propose to study whether or not these atypical antidepressants interfere with the regulation of the NE receptor coupled adenylate cyclase system under conditions of changed neurohormonal sensitivity and density of Beta-adrenoceptors or of Beta-adrenoceptors which are, as a consequence of serotonergic denervation, resistant to down-regulation by DMI. Our proposed studies on pineal N-acetyltransferase activity and Beta-receptor mediated glycogenlysis will generate answers to the question of whether or not the drug induced changes in the sensitivity of the NE receptor coupled adenylate cyclase system are reflected in a net deamplification or net amplification, respectively, of the NE signal. Taking advantage of the marked antidepressant induced changes in sensitivity of the NE receptor coupled adenylate cyclase, we will study the consequences of such changes on cyclic AMP dependent protein kinase activity and cyclic AMP dependent phosphorylation of proteins of synaptic membranes. Since phospholipids play a key role in the integrity of cell membranes, the activity of membrane bound enzymes and receptor mechanisms, we intend to examine the role of phosphilipid methylation in the process of desensitization of the NE sensitive adenylate cyclase by antidpressants and of the apparent """"""""uncoupling process"""""""" of Beta-adrenoceptors in brain tissue from animals lesioned with 5,7,-dihydroxytryptamine. The long term objective of our studies is to gain a molecular understanding of the complex aminergic and endocrine regulation of central Beta-adrenoceptor function and its relation to the pharmacotherapy and pathophysiology of affective disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH029228-09
Application #
3375084
Study Section
(SRC)
Project Start
1977-01-01
Project End
1988-03-31
Budget Start
1985-04-01
Budget End
1986-03-31
Support Year
9
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Sulser, Fridolin (2002) The role of CREB and other transcription factors in the pharmacotherapy and etiology of depression. Ann Med 34:348-56
Manier, D H; Shelton, R C; Ellis, T C et al. (2000) Human fibroblasts as a relevant model to study signal transduction in affective disorders. J Affect Disord 61:51-8
Onaivi, E S; Chaudhuri, G; Abaci, A S et al. (1999) Expression of cannabinoid receptors and their gene transcripts in human blood cells. Prog Neuropsychopharmacol Biol Psychiatry 23:1063-77
Chakrabarti, A; Ekuta, J E; Onaivi, E S (1998) Neurobehavioral effects of anandamide and cannabinoid receptor gene expression in mice. Brain Res Bull 45:67-74
Nalepa, I; Manier, D H; Gillespie, D D et al. (1998) Lack of beta adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxine. Eur Neuropsychopharmacol 8:227-32
Eiring, A; Sulser, F (1997) Increased synaptic availability of norepinephrine following desipramine is not essential for increases in GR mRNA. Short communication. J Neural Transm 104:1255-8
Shelton, R C; Mainer, D H; Sulser, F (1996) cAMP-dependent protein kinase activity in major depression. Am J Psychiatry 153:1037-42
Manier, D H; Eiring, A; Shelton, R C et al. (1996) Beta-adrenoceptor-linked protein kinase A (PKA) activity in human fibroblasts from normal subjects and from patients with major depression. Neuropsychopharmacology 15:555-61
Rossby, S P; Nalepa, I; Huang, M et al. (1995) Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant. Brain Res 687:79-82
Bieck, P R; Duhl, D M; Eiring, A et al. (1992) Dose-dependent down-regulation of beta-adrenoceptors by isoproterenol in rat C6 glioma cells. Eur J Pharmacol 225:171-4

Showing the most recent 10 out of 24 publications